HIV Vaccine Set To Begin Human Trials

An HIV vaccine from a team lead by Robert Gallo out of the Institute of Human Virology (IHV) in Baltimore, Maryland is set to begin human trials!

Gallo and his team have been developing the vaccine for the last 15 years and they're launching the first clinical trial in collaboration with Profectus BioSciences.

"The results in monkeys are interesting, but they're not perfect," Gallo said at an event at the institute's Baltimore headquarters to announce the human trial. "If we keep just using monkeys, we're never going anywhere. We need for humans to respond."

Science Mag reports:

Known as a phase I study, the trial expects to enroll 60 people and will simply assess safety and immune responses of the “full-length single chain” vaccine. “It’s a terrible name,” says Gallo, who is not one to mince words.

The vaccine contains a version of HIV’s surface protein, gp120, engineered so that it links to a few portions of a protein called the CD4 receptor. When HIV infects cells, gp120 first binds to the CD4 receptor on white blood cells and then “transitions” in such a way that hidden parts of the virus are exposed, allowing it to bind to a second receptor on the immune cells called CCR5. Once bound to both receptors, HIV can enter the white blood cell and establish an infection. The IHV vaccine aims to generate antibodies that bind to HIV’s gp120 when it’s in this transitional state, ultimately blocking attachment to CCR5, aborting the infection process. The development of the vaccine is being led by IHV’s George Lewis, whose team includes Antonio DeVico and Timothy Fouts.

Gallo, 78, says it has taken a long time to move this vaccine into the clinic because he and his group have done extensive testing in monkeys, faced the typical vaccine challenges of manufacturing a human-grade product, and have had to scramble for funding. “Was anything a lack of courage?” asks Gallo, who frequently asks and answers his own questions. “Sure. We wanted more and more answers before going into people.”

You can check out more info on the vaccine via The Baltimore Sun!

Such an exciting development! 

 

(H/T: NNNext)

Comments

+1
0
-1
[-]

Good day everyone,  I have been suffering from Hiv/Aids for over 4years now, and suddenly, i have spent all my money all to make sure i get healthy all day, but happily, last month , I came in contact with a traditional doctor also known as a chief priest on a newspaper who is called DR ABIOLE. who has help much people to cure their aids disease, firstly i taught it was a joke until i contacted him " 'dr.ABIOLA' " and he said that if i am ready for this work, i told him yes, and he collected my details and told me that after he has finished consulting his oracle he will run back to me on when to go for a medical check up, i was un healthyling surprise. And truly last week monday Dr ABIOLA called me to quickly go for a medical checkup, which I did, only to find out that I was not with any HiV disease anymore, my friends and families who left me before run back to me. I now found out that God in Heaven is using this man to bless and heal us all, he is a great and powerful man, again I say to you sir, that God almightly will uplift you and your great work you did for I and other people. Pls i will sincerely advice all Hiv patient to contact this great powerful man called Dr ABIOLA for your solutions now at 'deadly.diseases.cure@hotmail.com all call he on +2348100609098

+1
0
-1
[-]

This isn't the first HIV vaccine trial in humans. I'm currently enrolled in one and have been for the past few months. To accurately test the efficiency of the vaccine, you must be HIV negative... 

+1
0
-1
[-]

What a Crock!!! Gallo is and has always been a HUGE FRAUD!!!

+1
0
-1
[-]

I would very much be interested in being a test subject.  I will be HIV+ 30 years this December and have been undetectable for around 10 years.

Thank you!

Len

+1
0
-1
[-]

How do I become a test subject? I'm hiv undetectable since 2012 I currently take triumec

+1
0
-1
[-]

Generally the test subjects are taken from a particular HIV clinic or scouted for in various clinics. Then a questionnaire is done to see if they are suitable and likely some blood tests if they want to check for resistance etc. It is highly unlikely anyone can be a test subject randomly and they choose their guinea pigs very carefully. The cohort is quite small too - 60.

It doesn't say whether it's a preventative vaccine or a therapeutic as if it's preventative, if you are already HIV+, no matter how much undetectable, it's likely it won't be of use to us!

Add new comment